Clinical Trial

Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

Completed Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to test whether one pill that combines ezetimibe, rosuvastatin, and amlodipine can safely lower cholesterol and blood pressure in Korean adults with high blood pressure and high cholesterol.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-27.
Trial Details
NCT Number NCT07564726
Lead Sponsor Celltrion Pharm, Inc.
Conditions Hypertension, Hypercholesterolemia
Enrollment 163 participants
Start Date 2022-08-05
Primary Completion 2024-02-13 (estimated)
Study Completion 2024-02-13 (estimated)
Updated on ClinicalTrials.gov 2026-05-08